Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE

NCT00783510 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT00783510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00783510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
July 11, 2008
Completion date
February 1, 2024
Enrollment
849 (actual)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

jia, juvenile idiopathic arthritis